OraSure Technologies, Inc.

OSUR

US68554V1089

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
5.16 ^USD	+6.17%		-6.18%	-37.07%

May. 13	JPMorgan Adjusts OraSure Technologies Price Target to $6 From $7, Maintains Neutral Rating	MT
May. 08	Earnings Flash (OSUR) ORASURE TECHNOLOGIES Reports Q1 Revenue $54.1M, vs. Street Est of $52.3M	MT

OraSure Technologies, Inc. Provides Revenue Guidance for the Second Quarter of 2021

May 05, 2021 at 02:51 pm EDT

OraSure Technologies, Inc. provided revenue guidance for the second quarter of 2021.

Latest news about OraSure Technologies, Inc.

JPMorgan Adjusts OraSure Technologies Price Target to $6 From $7, Maintains Neutral Rating	May. 13	MT
Earnings Flash (OSUR) ORASURE TECHNOLOGIES Reports Q1 Revenue $54.1M, vs. Street Est of $52.3M	May. 08	MT
Earnings Flash (OSUR) ORASURE TECHNOLOGIES Reports Q1 EPS $0.04, vs. Street Est of $0.03	May. 08	MT
Transcript : OraSure Technologies, Inc., Q1 2024 Earnings Call, May 08, 2024	May. 08
OraSure Technologies, Inc. Provides Revenue Guidance for the Second Quarter of 2024	May. 08	CI
OraSure Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Transcript : OraSure Technologies, Inc., 2023 Earnings Call, Feb 27, 2024	Feb. 27
Earnings Flash (OSUR) ORASURE TECHNOLOGIES Posts Q4 Revenue $75.9M, vs. Street Est of $74.3M	Feb. 27	MT
Earnings Flash (OSUR) ORASURE TECHNOLOGIES Reports Q4 EPS $0.22, vs. Street Est of $0.11	Feb. 27	MT
OraSure Technologies, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
OraSure Technologies, Inc. Provides Revenue Guidance for the First Quarter 2024	Feb. 27	CI
OraSure Technologies, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 27	CI
OraSure Technologies, Inc. Seeks M&A	Feb. 26	CI
OraSure Technologies Leads Series B Funding, Strikes Distribution Rights With Sapphiros	Jan. 04	MT
Orasure Technologies, Inc. Secures Strategic Distribution Rights with Sapphiros	Jan. 04	CI
Transcript : OraSure Technologies, Inc. - Special Call	Jan. 04
Sapphiros AI Bio LLC announced that it has received $30 million in funding from OraSure Technologies, Inc.	Jan. 03	CI
Citigroup Adjusts OraSure Technologies Price Target to $9 From $7, Maintains Buy Rating	Dec. 11	MT
Tranche Update on OraSure Technologies, Inc.'s Equity Buyback Plan announced on August 5, 2008.	Nov. 08	CI
OraSure Technologies to Seek Acquisitions	Nov. 07	CI
Transcript : OraSure Technologies, Inc., Q3 2023 Earnings Call, Nov 07, 2023	Nov. 07
Earnings Flash (OSUR) ORASURE TECHNOLOGIES Posts Q3 Revenue $89.2M, vs. Street Est of $74.6M	Nov. 07	MT
Earnings Flash (OSUR) ORASURE TECHNOLOGIES Reports Q3 EPS $0.27, vs. Street Est of $0.08	Nov. 07	MT
OraSure Technologies, Inc. Provides Financial Guidance for the Fourth Quarter 2023	Nov. 07	CI
OraSure Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI

Chart OraSure Technologies, Inc.

Duration

Period

More charts

OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Sector

Medical Equipment, Supplies & Distribution

Calendar

10:00am - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for OraSure Technologies, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

5.16 USD

Average target price

6.75 USD

Spread / Average Target

+30.81%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ORASURE TECHNOLOGIES, INC.	-37.07%	382M
ABBOTT LABORATORIES	-4.82%	182B
MEDTRONIC PLC	+1.38%	111B
BECTON, DICKINSON AND COMPANY	-2.82%	68.48B
DEXCOM, INC.	+0.69%	49.69B
CENCORA, INC.	+8.54%	44.46B
HOYA CORPORATION	+2.33%	40.67B
METTLER-TOLEDO INTERNATIONAL, INC.	+20.50%	31.22B
WEST PHARMACEUTICAL SERVICES, INC.	+1.72%	26.09B
TERUMO CORPORATION	+15.30%	25.32B

Other Medical Equipment, Supplies & Distribution